Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Vinnie Fagan


Postdoctoral Researcher

I completed my PhD in 2011 at the School of Chemistry, National University of Ireland Galway. My PhD involved the synthesis and biological evaluation of novel imidazo-benzimidazole quinone anti-cancer compounds.

Following my PhD I spent two years working as a Postdoctoral Research Fellow at the School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia. I designed and synthesized a library of synthetic lipopeptide based self-adjuvanting vaccine candidates against Group A Streptococcus.

In 2014 I returned to Ireland where I took up employment as a Technical Development Chemist, GlaxoSmithKline (Currabinny, Cork, Ireland). I provided technical chemical expertise relating to the production of a range of active pharmaceutical ingredients.

In March 2016 I commenced my current role as Postdoctoral Scientist – Medicinal Chemistry, to design and synthesize small molecule inhibitors of epigenetic targets as part of ongoing epigenetic target validation studies by the Structural Genomics Consortium (SGC)-Oxford.